ATE397000T1 - Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs - Google Patents

Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs

Info

Publication number
ATE397000T1
ATE397000T1 AT05750033T AT05750033T ATE397000T1 AT E397000 T1 ATE397000 T1 AT E397000T1 AT 05750033 T AT05750033 T AT 05750033T AT 05750033 T AT05750033 T AT 05750033T AT E397000 T1 ATE397000 T1 AT E397000T1
Authority
AT
Austria
Prior art keywords
tetrahydropyridothiophenes
cancer
treatment
compounds
proliferative
Prior art date
Application number
AT05750033T
Other languages
English (en)
Inventor
Klaus Pekari
Thomas Baer
Mathias Schmidt
Thomas Beckers
Bjoern Bartels
Petra Gimmnich
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Application granted granted Critical
Publication of ATE397000T1 publication Critical patent/ATE397000T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT05750033T 2004-06-04 2005-06-03 Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs ATE397000T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04102531 2004-06-04

Publications (1)

Publication Number Publication Date
ATE397000T1 true ATE397000T1 (de) 2008-06-15

Family

ID=34929170

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05750033T ATE397000T1 (de) 2004-06-04 2005-06-03 Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs

Country Status (9)

Country Link
US (2) US7517986B2 (de)
EP (1) EP1756118B1 (de)
JP (1) JP2008501668A (de)
AT (1) ATE397000T1 (de)
AU (1) AU2005250184B2 (de)
CA (1) CA2568718A1 (de)
DE (1) DE602005007220D1 (de)
ES (1) ES2308504T3 (de)
WO (1) WO2005118592A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818547B1 (fr) * 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
AU2005249718B2 (en) 2004-05-28 2011-01-27 4Sc Ag Tetrahydropyridothiophenes
WO2005118592A1 (en) * 2004-06-04 2005-12-15 Altana Pharma Ag Tetrahydropyridothiophenes for use in the treatment of cancer
US7714134B2 (en) 2004-06-11 2010-05-11 4Sc Ag Compounds and use of tetrahydropyridothiophenes
EP1851229A1 (de) * 2005-02-09 2007-11-07 Nycomed GmbH Tetrahydropyridothiophene zur behandlung von proliferativen krankheiten wie krebs
WO2006125813A2 (en) * 2005-05-25 2006-11-30 Nycomed Gmbh Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251169A1 (en) * 2005-05-25 2006-11-30 4Sc Ag Tetrahydropyridothiophenes for use in the treatment of cancer
US20100285149A1 (en) * 2006-08-16 2010-11-11 Klaus Pekari Novel tetrahydropyridothiophenes
CN102188698B (zh) * 2010-03-08 2014-10-01 上海南方模式生物科技发展有限公司 核糖核酸酶和青蒿素的联用
KR101633453B1 (ko) * 2015-06-17 2016-06-24 한국과학기술연구원 대사성 글루타메이트 수용체 1, 5에 활성을 보이는 신규 테트라하이드로티에노[2,3-ｃ]피리딘 유도체
CN108558848A (zh) * 2018-04-19 2018-09-21 华东师范大学 一种环烷烃并噻吩衍生物及其制备方法和医药用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1225167B (de) * 1965-04-07 1966-09-22 Huels Chemische Werke Ag Verfahren zur Herstellung aliphatischer, aromatischer oder gemischt aliphatisch-aromatischer Sulfone
JPS5498337A (en) * 1978-01-06 1979-08-03 Dai Ichi Seiyaku Co Ltd Anticarcinogenic and/or antimetastatic agent
DD272078A1 (de) 1986-04-15 1989-09-27 Dresden Arzneimittel Verfahren zur herstellung von 6-substituierten 2-acylamio-4,5,6,7-tetrahydro-thieno[2,3-c]-pyridin-3-carbonsaeure-derivaten
DE4039734A1 (de) * 1990-12-13 1992-06-17 Basf Ag Substituierte 2-aminothiophene enthaltende herbizide mittel
JP3074640B2 (ja) * 1995-12-22 2000-08-07 インターナショナル・ビジネス・マシーンズ・コーポレ−ション 液晶表示装置の駆動方法
GB9614718D0 (en) 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
KR20010041814A (ko) * 1998-03-12 2001-05-25 온토젠 코포레이션 단백질 티로신 포스파타제（ｐｔｐａｓｅｓ）의 조절제
WO1999046267A1 (en) 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
EP1392283A4 (de) * 2001-05-16 2004-10-20 Cytovia Inc Substituierte cumarine und chinoline als caspase-aktivatoren
US20040171603A1 (en) * 2001-05-18 2004-09-02 Janos Pato Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
US20030232994A1 (en) * 2001-10-04 2003-12-18 Shao-Po Lu Bicyclic thiophene derivatives and combinatorial libraries thereof
JP4103425B2 (ja) * 2002-03-28 2008-06-18 セイコーエプソン株式会社 電気光学装置、電子機器及び投射型表示装置
AU2003268529B2 (en) * 2002-09-12 2007-08-09 Merck & Co., Inc. Method of treating diabetes and related conditions
DE60325985D1 (de) 2002-09-12 2009-03-12 Merck & Co Inc Substituierte bizyklische thiophen-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren
IL154306A0 (en) 2003-02-05 2003-09-17 Rimonyx Pharmaceuticals Ltd Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof
US7138529B2 (en) 2003-04-16 2006-11-21 Hoffmann-La Roche Inc. Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
US20050085531A1 (en) 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
GB0324653D0 (en) 2003-10-22 2003-11-26 Syngenta Participations Ag Fungicides
WO2005060711A2 (en) 2003-12-19 2005-07-07 Elixir Pharmaceuticals, Inc. Methods of treating a disorder
US7745630B2 (en) * 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
AU2005249718B2 (en) 2004-05-28 2011-01-27 4Sc Ag Tetrahydropyridothiophenes
WO2005118592A1 (en) * 2004-06-04 2005-12-15 Altana Pharma Ag Tetrahydropyridothiophenes for use in the treatment of cancer
US7714134B2 (en) 2004-06-11 2010-05-11 4Sc Ag Compounds and use of tetrahydropyridothiophenes

Also Published As

Publication number Publication date
US7517986B2 (en) 2009-04-14
US20070213360A1 (en) 2007-09-13
EP1756118A1 (de) 2007-02-28
AU2005250184A1 (en) 2005-12-15
DE602005007220D1 (de) 2008-07-10
ES2308504T3 (es) 2008-12-01
AU2005250184B2 (en) 2011-04-21
EP1756118B1 (de) 2008-05-28
JP2008501668A (ja) 2008-01-24
WO2005118592A1 (en) 2005-12-15
CA2568718A1 (en) 2005-12-15
US20090163538A1 (en) 2009-06-25
WO2005118592A8 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
ATE397000T1 (de) Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
NL301145I2 (nl) Tirbanibulin
ES2309765T3 (es) Tetrahidropiridotiofenos.
ATE453653T1 (de) Platinkomplexe zur behandlung von tumoren
DE602006014843D1 (de) Verwendung von hif 1alfa modulatoren zur behandlung von krebs
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
ATE517896T1 (de) P38-kinase-inhibitoren
CY1109985T1 (el) Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων
ATE406351T1 (de) Kondensierte heteroyralderivate zur verwendung als p38-kinase-inhibitoren
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
ATE471334T1 (de) Phosphoramidatderivate von nukleosidverbindungen zur verwendung bei der behandlung von krebs
ATE471324T1 (de) Triazolophthalazine
ATE542536T1 (de) 3-ä4-(dibenzoäb,füä1,4üoxazepin-11-yl)-piperazi - 1-ylü-2,2-dimethyl propansäure zur verwendung in der behandlung von schlafstörungen
DE602005024572D1 (de) Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DE502005007105D1 (de) 4-amino-5-oxo-8-phenyl-5h-pyrido-ä2,3-dü-pyrimidin-derivate als inhibitoren der tyrosinkinasen und der raf-kinasen zur behandlung von tumoren
WO2006125815A3 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
WO2006125813A3 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
ATE478076T1 (de) Azaxanthonen zur behandlung von tumoren
DE602005019770D1 (de) Medizinische zusammensetzung zur behandlung von krebs oder diabetes
ATE550019T1 (de) Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs
ATE521351T1 (de) Verwendung von 7-t-butoxyiminomethylcamptothecin zur behandlung von gebärmuttertumoren
ATE476185T1 (de) Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen
AT501262B8 (de) Verwendung von gallium(iii)-komplexen zur behandlung von tumoren des urothelialtraktes
DE502006009303D1 (de) Acylglycerophospholipide zur behandlung von krebs-begleiterscheinungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties